ResMed (Germany) Buy Hold or Sell Recommendation
| RME Stock | EUR 230.00 3.20 1.41% |
Assuming the 90 days horizon and your above-average risk tolerance, our recommendation regarding ResMed Inc is 'Hold'. Macroaxis provides ResMed buy-hold-or-sell recommendation only in the context of selected investment horizon and investor attitude towards risk assumed by holding ResMed positions.
Check out ResMed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. Note, we conduct extensive research on individual companies such as ResMed and provide practical buy, sell, or hold advice based on investors' constraints. ResMed Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
ResMed |
Execute ResMed Buy or Sell Advice
The ResMed recommendation should be used to complement the buy-or-sell advice compiled from the current analysts' consensus on ResMed Inc. Macroaxis does not own or have any residual interests in ResMed Inc or other equities on which the buy-or-sell advice is provided. Please provide your input below to execute ResMed's advice using the current market data and latest reported fundamentals.
Time Horizon
Risk Tolerance
 |  |
Hold
Market Performance | Insignificant | Details | |
Volatility | Very steady | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Fairly Valued | Details | |
Odds Of Distress | Low | Details | |
Economic Sensitivity | Slowly supersedes the market | Details | |
Analyst Consensus | Not Available | Details | |
Reporting Quality (M-Score) | Inapplicable | Details |
ResMed Trading Alerts and Improvement Suggestions
| The company has €765.33 Million in debt which may indicate that it relies heavily on debt financing | |
| About 67.0% of the company shares are owned by institutional investors |
ResMed Returns Distribution Density
The distribution of ResMed's historical returns is an attempt to chart the uncertainty of ResMed's future price movements. The chart of the probability distribution of ResMed daily returns describes the distribution of returns around its average expected value. We use ResMed Inc price's Value At Risk and its Upside Potential as a relative measure of the distribution. The graph of the distribution of ResMed returns is essential to provide solid investment advice for ResMed.
| Mean Return | 0.12 | Value At Risk | -2.62 | Potential Upside | 2.10 | Standard Deviation | 1.67 |
Return Density |
| Distribution |
Investment risk management requires an estimate of the probability of extreme price changes. Therefore, the correct representation of the distribution of ResMed historical returns presented in an easy-to-digest graphical form helps investors and money managers understand the risk-reward trade-off of different investement strategies.
ResMed Greeks
Most traded equities are subject to two types of risk - systematic (i.e., market) and unsystematic (i.e., nonmarket or company-specific) risk. Unsystematic risk is the risk that events specific to ResMed or Healthcare sector will adversely affect the stock's price. This type of risk can be diversified away by owning several different stocks in different industries whose stock prices have shown a small correlation to each other. On the other hand, systematic risk is the risk that ResMed's price will be affected by overall stock market movements and cannot be diversified away. So, no matter how many positions you have, you cannot eliminate market risk. However, you can measure a ResMed stock's historical response to market movements and buy it if you are comfortable with its volatility direction. Beta and standard deviation are two commonly used measures to help you make the right decision.
α | Alpha over Dow Jones | 0.1 | |
β | Beta against Dow Jones | 0.39 | |
σ | Overall volatility | 1.71 | |
Ir | Information ratio | 0.05 |
ResMed Volatility Alert
ResMed Inc has relatively low volatility with skewness of -0.05 and kurtosis of 3.8. Understanding different market volatility trends often help investors to time the market. Properly using volatility indicators enable traders to measure ResMed's stock risk against market volatility during both bullish and bearish trends. The higher level of volatility that comes with bear markets can directly impact ResMed's stock price while adding stress to investors as they watch their shares' value plummet. This usually forces investors to rebalance their portfolios by buying different financial instruments as prices fall.ResMed Fundamentals Vs Peers
Comparing ResMed's fundamentals to the average values of its peers is one of the most widely used and accepted methods of equity analyses. It helps to analyze ResMed's direct or indirect competition across all of the common fundamentals between ResMed and the related equities. This way, we can detect undervalued stocks with similar characteristics as ResMed or determine the stocks which would be an excellent addition to an existing portfolio. Peer analysis of ResMed's fundamental indicators could also be used in its relative valuation, which is a method of valuing ResMed by comparing valuation metrics with those of similar companies.
| Better Than Average | Worse Than Average | Compare ResMed to competition |
| Fundamentals | ResMed | Peer Average |
| Return On Equity | 0.24 | -0.31 |
| Return On Asset | 0.12 | -0.14 |
| Profit Margin | 0.22 % | (1.27) % |
| Operating Margin | 0.28 % | (5.51) % |
| Current Valuation | 31.17 B | 16.62 B |
| Shares Outstanding | 146.91 M | 571.82 M |
| Shares Owned By Insiders | 1.29 % | 10.09 % |
| Shares Owned By Institutions | 66.53 % | 39.21 % |
| Price To Earning | 41.49 X | 28.72 X |
| Price To Book | 9.40 X | 9.51 X |
| Price To Sales | 8.54 X | 11.42 X |
| Revenue | 3.58 B | 9.43 B |
| Gross Profit | 2.06 B | 27.38 B |
| EBITDA | 1.19 B | 3.9 B |
| Net Income | 779.44 M | 570.98 M |
| Cash And Equivalents | 147.13 M | 2.7 B |
| Cash Per Share | 1.03 X | 5.01 X |
| Total Debt | 765.33 M | 5.32 B |
| Debt To Equity | 61.30 % | 48.70 % |
| Current Ratio | 2.06 X | 2.16 X |
| Book Value Per Share | 25.45 X | 1.93 K |
| Cash Flow From Operations | 351.15 M | 971.22 M |
| Earnings Per Share | 5.17 X | 3.12 X |
| Price To Earnings To Growth | 1.74 X | 4.89 X |
| Target Price | 261.67 | |
| Number Of Employees | 8.16 K | 18.84 K |
| Beta | 0.47 | -0.15 |
| Market Capitalization | 29.28 B | 19.03 B |
| Total Asset | 5.1 B | 29.47 B |
| Z Score | 22.8 | 8.72 |
| Annual Yield | 0.01 % | |
| Five Year Return | 1.34 % | |
| Net Asset | 5.1 B |
ResMed Market Momentum
Traders often use several daily momentume indicators to supplement a more traditional technical analysis when analyzing securities such as ResMed . With many different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Daily Balance Of Power | 9.2 T | |||
| Rate Of Daily Change | 1.01 | |||
| Day Median Price | 230.0 | |||
| Day Typical Price | 230.0 | |||
| Price Action Indicator | 1.6 | |||
| Period Momentum Indicator | 3.2 | |||
| Relative Strength Index | 49.11 |
About ResMed Buy or Sell Advice
When is the right time to buy or sell ResMed Inc? Buying financial instruments such as ResMed Stock isn't very hard. However, what challenging for most investors is doing it at the right time to beat the market. Proper market timing is something most people cannot do without sophisticated tools, which help to isolate the right opportunities. Macroaxis provides hands-on modules to deliver winning trades and diversify your portfolios on a daily basis. Most of our advising modules are very easy to use and apply.
Please read more on our stock advisor page.
Use Investing Ideas to Build Portfolios
In addition to having ResMed in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Defense Thematic Idea Now
Defense
Fama and French investing themes focus on testing asset pricing under different economic assumptions. The Defense theme has 15 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Defense Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Information and Resources on Investing in ResMed Stock
When determining whether ResMed Inc is a strong investment it is important to analyze ResMed's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact ResMed's future performance. For an informed investment choice regarding ResMed Stock, refer to the following important reports:Check out ResMed Analyst Recommendation to compare Macroaxis Buy or Sell Recommendation with the current analyst consensus. To check ratings for multiple equity instruments, please use the Instant Ratings tool. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.